PMC5875408_01
(A) Pretreatment MRI (T1_tra), case 1; (B) follow-up MRI (T1_tra) 6 weeks after treatment, case 1; (C) pretreatment MRI (T1_dixon_tra), case 2; (D) follow-up MRI (T1_tra) 5 months after treatment, case 2. Arrows indicate primary tumor.. Abbreviation: MRI, magnetic resonance imaging.
cmar-10-583Fig2.jpg
PMC5875408_02_cmar-10-583Fig2.jpg
f2-cmar-10-583
CT and MRI of the chest, abdomen, and pelvis revealed a tumor of the perineum which was infiltrating the penile cavernous body and the prostate (Figure 2C). MRI scans showed a partial remission with residual contrast enhancement in the pelvic floor (Figure 2D), the cavernous body, and the prostate, and no signs of progression.
PMC5875408_02
(A) Pretreatment MRI (T1_tra), case 1; (B) follow-up MRI (T1_tra) 6 weeks after treatment, case 1; (C) pretreatment MRI (T1_dixon_tra), case 2; (D) follow-up MRI (T1_tra) 5 months after treatment, case 2. Arrows indicate primary tumor.. Abbreviation: MRI, magnetic resonance imaging.
cmar-10-583Fig2.jpg
PMC5875408_02_cmar-10-583Fig2.jpg
f2-cmar-10-583
CT and MRI of the chest, abdomen, and pelvis revealed a tumor of the perineum which was infiltrating the penile cavernous body and the prostate (Figure 2C). MRI scans showed a partial remission with residual contrast enhancement in the pelvic floor (Figure 2D), the cavernous body, and the prostate, and no signs of progression.
PMC5875408_03